Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT1 | P17948 | 1/20 | 0.51 |
| ▸ | FLT4 | P35916 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250256 | 0.84 | FLT1 (0.53) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL109654 | 0.83 | SMN1; SMN2 (0.63) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL30628195 | 0.83 | FLT1 (0.51) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL4574528 | 0.83 | FLT1 (0.51) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL874097 | 0.83 | ALDH1A1 (0.47) | SMN1; SMN2TSHRCASP1RAB9ANPC1 | |
| SCHEMBL26019671 | 0.82 | FLT1 (0.47) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL2010267 | 0.81 | CYP2A6 (0.46) | SMN1; SMN2RAB9ANPC1MAPTALDH1A1 | |
| SCHEMBL11255876 | 0.81 | FLT1 (0.50) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL2468739 | 0.81 | KDM4E (0.55) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL9555496 | 0.81 | FLT1 (0.50) | FLT1FLT4KDRSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381182-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | AMYGDALA NEUROSCIENCES, INC. (US) | 2025-12-18 | — | — | US | disclosed |
| US-12351569-B2 | ALDH-2 inhibitor compounds and methods of use | AMYGDALA NEUROSCIENCES, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| EP-4540237-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | Amygdala Neurosciences, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| US-12018009-B2 | ALDH-2 inhibitor compounds and methods of use | AMYGDALA NEUROSCIENCES, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| CN-117645607-A | Electroluminescent material and application thereof | 北京燕化集联光电技术有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117535046-A | Luminescent material composition and application thereof | 北京燕化集联光电技术有限公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2023244574-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | AMYGDALA NEUROSCIENCES, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| US-20230399307-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | AMYGDALA NEUROSCIENCES, INC. (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399315-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | AMYGDALA NEUROSCIENCES, INC. (US) | 2023-12-14 | — | — | US | disclosed |
| US-11482684-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-10-25 | — | — | US | disclosed |
| WO-1999065897-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | CHIRON CORPORATION (US) | 1999-12-23 | — | — | WO | disclosed |
| CN-1129952-A | Detergent-package combination | PROCTER & GAMBLE (US) | 1996-08-28 | — | — | CN | disclosed |
| US-5117057-A | Insecticidal N' substituted-N-N'-disubstituted-hydrazines | ROHM AND HAAS COMPANY (US) | 1992-05-26 | — | — | US | disclosed |
| US-4588715-A | ASNTICHOLESTEROL AGENTS, ATHEROSCLEROSIS, SILYLPHENYL DERIVATIVES | SANDOZ, INC. (US) | 1986-05-13 | — | — | US | disclosed |
| US-4431797-A | ELECTROLYTIC REDUCTION OF TEREPHTHALIC ACID TO AMMONIUM SALT OF P- | STANDARD OIL COMPANY (INDIANA) (US) | 1984-02-14 | — | — | US | disclosed |
| US-4182847-A | Monomers for poly(methylenebenzoate) polymers from toluic acid compounds | STANDARD OIL COMPANY (INDIANA) (US) | 1980-01-08 | — | — | US | disclosed |
| US-4122116-A | HERBICIDES | DEUTSCHE GOLD- UND SILBER- SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-10-24 | — | — | US | disclosed |
| US-4108877-A | REACTING ACYL HALIDE WITH COPPER CYANIDE WITH HEATING IN THE PRESENCE OF A CARBOXYLIC ACID NITRILE AND AN ORGANIC SOLVENT | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-08-22 | — | — | US | disclosed |
| US-4108875-A | REACTING ACYL HALIDE WITH AN ALKALI METAL CYANIDE AND A COPPER(I) SALT IN THE PRESENCE OF A CARBOXYLIC ACID NITRILE WITH HEATING | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-08-22 | — | — | US | disclosed |
| US-4006009-A | 1-Thiadiazolyl-6-acyloxytetrahydropyrimidinone herbicides | VELSICOL CHEMICAL CORPORATION (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11482684-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | FLT1 4782/4885FLT4 4450/4885KDR 3311/4885 |
| US-20230399315-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | ALDH1A1, ALDH2, ALDH3A1 | FLT1 4026/4885FLT4 4203/4885KDR 2180/4885 |
| US-20230399307-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | ALDH1A1, ALDH2, ALDH3A1 | FLT1 4028/4885FLT4 4208/4885KDR 2209/4885 |
| US-20250381182-A1 | ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE | ALDH1A1, ALDH2, ALDH3A1 | FLT1 4026/4885FLT4 4203/4885KDR 2180/4885 |
| US-12351569-B2 | ALDH-2 inhibitor compounds and methods of use | ALDH1A1, ALDH2, ALDH3A1 | FLT1 4028/4885FLT4 4208/4885KDR 2209/4885 |
| US-12018009-B2 | ALDH-2 inhibitor compounds and methods of use | ALDH1A1, ALDH2, ALDH3A1 | FLT1 4026/4885FLT4 4203/4885KDR 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.